Three Years After Experimental Vaccine, These Patients Are Still Cancer-Free
A kidney cancer vaccine candidate has shown great promise in an early Phase I trial published this week.
![Three Years After Experimental Vaccine, These Patients Are Still Cancer-Free](https://gizmodo.com/app/uploads/2024/09/Vaccine-vial.jpg)
![Vaccine Vials](https://gizmodo.com/app/uploads/2024/09/Vaccine-vial.jpg)
A kidney cancer vaccine candidate has shown great promise in an early Phase I trial published this week.